277 related articles for article (PubMed ID: 8812632)
1. Prolactin suppression enhances the effects of perioperative donor-specific blood transfusions on graft survival.
Martinelli GP; Liu H; Clarke WP; Heisenleder DJ; Knight RJ
J Surg Res; 1996 Aug; 64(2):190-7. PubMed ID: 8812632
[TBL] [Abstract][Full Text] [Related]
2. Long-term prolongation of cardiac allografts by subtherapeutic levels of cyclosporine in rats conditioned with pretransplant blood transfusions and cyclosporine.
Martinelli GP; Chung-Loy R; Sher L; Racelis D; Miller CM; Schanzer H
Transplantation; 1985 Jan; 39(1):1-5. PubMed ID: 3880956
[TBL] [Abstract][Full Text] [Related]
3. Nutritional immunomodulation enhances cardiac allograft survival in rats treated with donor-specific transfusion and cyclosporine.
Levy AE; Alexander JW
Transplantation; 1995 Oct; 60(8):812-5. PubMed ID: 7482740
[TBL] [Abstract][Full Text] [Related]
4. Indefinite allograft survival induced by the combination of multiple donor-specific transfusions, cyclosporine, and an anti-T cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation. The importance of prolonged posttransplant cyclosporine coverage.
Tchervenkov JI; Cofer BR; Davies C; Alexander JW
Transplantation; 1995 Mar; 59(6):821-4. PubMed ID: 7701575
[TBL] [Abstract][Full Text] [Related]
5. Small bowel transplantation in the rat. Effect of pretransplant blood transfusions and cyclosporine on host survival.
Martinelli GP; Knight RK; Kaplan S; Racelis D; Dikman SH; Schanzer H
Transplantation; 1988 Jun; 45(6):1021-6. PubMed ID: 3260047
[TBL] [Abstract][Full Text] [Related]
6. Extensive prolongation of rat renal allograft survival following donor or nonspecific transfusions and concomitant immunosuppressant.
Martin DC; Hewitt CW; Black KS; Dowdy SF; Quintero CS; Reyes M
Transplantation; 1987 Jun; 43(6):790-4. PubMed ID: 3296345
[TBL] [Abstract][Full Text] [Related]
7. Effect of ultraviolet-B-irradiated donor-specific blood transfusions and peritransplant immunosuppression with cyclosporine on rat cardiac allograft survival.
Oluwole SF; Lau HT; Reemtsma K; Hardy MA
Transplantation; 1988 Feb; 45(2):293-7. PubMed ID: 3278417
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin, cyclosporine, and perioperative donor-specific transfusions induce prolongation of cardiac allograft survival in the rat.
Knight RJ; Polokoff EG; Martinelli GP
Transplantation; 1994 Nov; 58(9):1014-20. PubMed ID: 7974728
[TBL] [Abstract][Full Text] [Related]
9. Effect of a PGE-1 analogue on the survival of cardiac transplant rats.
Gracida Juárez C; Mechor Ortíz JL; Mozes MF
Arch Med Res; 1992; 23(1):55-8. PubMed ID: 1308792
[TBL] [Abstract][Full Text] [Related]
10. The specific monocarboxylate transporter-1 (MCT-1) inhibitor, AR-C117977, induces donor-specific suppression, reducing acute and chronic allograft rejection in the rat.
Ekberg H; Qi Z; Pahlman C; Veress B; Bundick RV; Craggs RI; Holness E; Edwards S; Murray CM; Ferguson D; Kerry PJ; Wilson E; Donald DK
Transplantation; 2007 Nov; 84(9):1191-9. PubMed ID: 17998876
[TBL] [Abstract][Full Text] [Related]
11. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.
Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A
Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895
[TBL] [Abstract][Full Text] [Related]
12. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
Siemionow MZ; Izycki DM; Zielinski M
Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide pretreatment of cyclosporine-treated rats enhances cardiac allograft survival.
Lin H; Wei RQ; Bolling SF
J Surg Res; 1993 Oct; 55(4):441-5. PubMed ID: 8412131
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the mechanism of active enhancement of renal allograft survival by blood transfusion.
Quigley RL; Wood KJ; Morris PJ
Immunology; 1988 Mar; 63(3):373-81. PubMed ID: 2965097
[TBL] [Abstract][Full Text] [Related]
15. A strategy for generating consistent long-term donor-specific tolerance to solid organ allografts.
Levy AE; Alexander JW; Babcock GF
Transpl Immunol; 1997 Jun; 5(2):83-8. PubMed ID: 9269029
[TBL] [Abstract][Full Text] [Related]
16. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
Huang WH; Yan Y; De Boer B; Bishop GA; House AK
Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
[TBL] [Abstract][Full Text] [Related]
17. Combined donor leucocyte administration and immunosuppressive drug treatment for survival of rat heart allografts.
den Dulk M; Wang C; Li J; Clark DA; Hibberd AD; Terpstra OT; McCaughan GW; Bishop GA
Transpl Immunol; 2004 Nov; 13(3):177-84. PubMed ID: 15381200
[TBL] [Abstract][Full Text] [Related]
18. Role of thymus in operational tolerance induction in limb allograft transplant model.
Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A
Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin graft pretreatment in small bowel and kidney transplantation in the rat.
Chen H; Xu D; Qi S; Wu J; Luo H; Daloze P
Transplantation; 1995 Apr; 59(8):1084-9. PubMed ID: 7732551
[TBL] [Abstract][Full Text] [Related]
20. A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance.
Josien R; Douillard P; Guillot C; Müschen M; Anegon I; Chetritt J; Menoret S; Vignes C; Soulillou JP; Cuturi MC
J Clin Invest; 1998 Dec; 102(11):1920-6. PubMed ID: 9835616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
